Matthew E. Garth - 11 Jul 2025 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Reporting relationship: EVP & CFO
Issuer ticker: XRAY
Reported as of: 11 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jul 2025, 16:41:39 UTC
Prior SEC filing: 30 May 2025
Next SEC filing: 15 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Jessica Causey, Attorney-in-Fact for Matthew E. Garth

Key filing fact

Matthew E. Garth filed Form 4 for DENTSPLY SIRONA Inc. (XRAY) on 15 Jul 2025.

Key facts

This page summarizes Matthew E. Garth's Form 4 filing for DENTSPLY SIRONA Inc. (XRAY).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Jul 2025, 16:41.

Change

Previous filing in this sequence was filed on 30 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001695300 Primary reporting owner

GARTH MATTHEW E

Relationship: EVP & CFO
Address: C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE
Signature: /s/ Jessica Causey, Attorney-in-Fact for Matthew E. Garth
Signature date: 15 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XRAY transaction

Common Stock

Award

Transaction value: $0
Shares: +432
Change %: +1%
Price: $0.000000
Shares after: 43,455
Date: 11 Jul 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.